Levofloxacin / Tylosin Suspension Suppliers & Bulk Manufacturers
Available Forms: Suspension
Available Strengths: 50mg+100mg, 50mg+200mg
Reference Brands: LevoTyl (India), Levoflox Tylosin (LATAM), Bectoflox
Category:
Veterinary Product
-
Levofloxacin / Tylosin suspension is available in Suspension
and strengths such as 50mg+100mg, 50mg+200mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Levofloxacin / Tylosin suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Levofloxacin / Tylosin suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tylosin phosphate is a macrolide antibiotic commonly used in cattle, particularly in North America, to control liver abscesses and improve herd health. This study evaluated the effects of subtherapeutic, in-feed administration of tylosin phosphate (11 ppm) over 197 days and its subsequent withdrawal 28 days prior to slaughter on macrolide resistance in enterococci. Fecal samples from treated and untreated steers were analyzed for species diversity, antimicrobial susceptibility, resistance genes, and genetic profiles.
Results showed that tylosin administration increased the proportion of erythromycin-resistant (eryR) and tylosin-resistant (tylR) enterococci in the gut. However, after withdrawal of tylosin from the feed, the proportion of resistant enterococci steadily declined, ultimately showing no significant difference compared to untreated cattle. Among 504 isolates, Enterococcus hirae predominated, followed by E. villorum, E. faecium, E. durans, E. casseliflavus, E. mundtii, E. gallinarum, E. faecalis, and E. thailandicus. Resistant isolates harbored erm(B) and/or msrC genes. The study highlights that antibiotic withdrawal prior to slaughter effectively reduces the presence of macrolide-resistant enterococci entering the food chain, emphasizing responsible tylosin use in livestock management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing